G-protein beta 3 subunit polymorphisms and essential hypertension: a case-control association study in northern Han Chinese

被引:0
作者
Li, Mei
Zhang, Bei
Li, Chuang
Liu, Jie-Lin
Wang, Li-Juan
Liu, Ya
Wang, Zuo-Guang
Wen, Shao-Jun [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Dept Hypertens Res, Beijing 100029, Peoples R China
[2] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China
基金
北京市自然科学基金;
关键词
G protein beta 3 subunit gene; Haplotype; Hypertension; Polymorphism; SAMPLE-SIZE CALCULATIONS; C825T POLYMORPHISM; VARIANT; GENE; POPULATION; DISEASES; JAPANESE; POWER;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To explore the association between the three polymorphisms [C825T, C1429T and G(-350) A] of the gene encoding the G protein beta 3 subunit (GNB3) and hypertension by performing a case-control study in the northern Han Chinese population. Methods We recruited 731 hypertensive patients and 673 control subjects (the calculated power value was > 0.8). Genotyping was performed to identify C825T, C1429T and G(-350) A polymorphisms using the TaqMan assay. Comparisons of allelic and genotypic frequencies between cases and controls were made by using the chi-square test. Logistic regression analyses were performed to investigate the relationships between the three polymorphisms of GNB3 gene under different genetic models (additive, dominant and recessive models). Results The genotype distribution and allele frequencies of C825T, C1429T and G(-350) A polymorphisms did not differ significantly between hypertensive patients and control subjects, either when the full sample was assessed, or when the sample was stratified by gender. No significant association was observed between C825T, C1429T and G(-350) A polymorphisms and the risk of essential hypertension in any genetic model. Linkage disequilibrium was only detected between C825T and C1429T polymorphisms. Haplotype analyses observed that none of the three estimated haplotypes significantly increased the risk of hypertension. Conclusions Our study suggested that the GNB3 gene polymorphisms [C825T, C1429T and G(-350) A] were not significantly associated with essential hypertension in northern Han Chinese population.
引用
收藏
页码:127 / 134
页数:8
相关论文
共 30 条
[1]  
[Anonymous], S CHINA J CARDIOVASC
[2]   G-protein β3 subunit C825T variant and ambulatory blood pressure in essential hypertension [J].
Beige, J ;
Hohenbleicher, H ;
Distler, A ;
Sharma, AM .
HYPERTENSION, 1999, 33 (04) :1049-1051
[3]   G-protein β3 subunit gene (GNB3) variant in causation of essential hypertension [J].
Benjafield, AV ;
Jeyasingam, CL ;
Nyholt, DR ;
Griffiths, LR ;
Morris, BJ .
HYPERTENSION, 1998, 32 (06) :1094-1097
[4]   The Role of G Protein β3 Subunit Polymorphisms C825T, C1429T, and G5177A in Turkish Subjects with Essential Hypertension [J].
Cabadak, Hulya ;
Orun, Oya ;
Nacar, Cevdet ;
Dogan, Yuksel ;
Guneysel, Ozlem ;
Fak, Ali Serdar ;
Kan, Beki .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2011, 33 (03) :202-208
[5]   Association study designs for complex diseases [J].
Cardon, LR ;
Bell, JI .
NATURE REVIEWS GENETICS, 2001, 2 (02) :91-99
[6]   GENETIC ASSOCIATION STUDY IN PSYCHIATRY - ANALYTICAL EVALUATION AND A RECOMMENDATION [J].
CAREY, G .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 54 (04) :311-317
[7]   Essential hypertension Part I: Definition and etiology [J].
Carretero, OA ;
Oparil, S .
CIRCULATION, 2000, 101 (03) :329-335
[8]   Genetic relationship of populations in China [J].
Chu, JY ;
Huang, W ;
Kuang, SQ ;
Wang, JM ;
Xu, JJ ;
Chu, ZT ;
Yang, ZQ ;
Lin, KQ ;
Li, P ;
Wu, M ;
Geng, ZC ;
Tan, CC ;
Du, RF ;
Jin, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11763-11768
[9]   Association between the C825T polymorphism of the G protein β3-subunit gene and hypertension in blacks [J].
Dong, YB ;
Zhu, HD ;
Sagnella, GA ;
Carter, ND ;
Cook, DG ;
Cappuccio, FP .
HYPERTENSION, 1999, 34 (06) :1193-1196
[10]   Power and sample size calculations for studies involving linear regression [J].
Dupont, WD ;
Plummer, WD .
CONTROLLED CLINICAL TRIALS, 1998, 19 (06) :589-601